查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702245

細胞治療市場規模、佔有率、趨勢及預測（按細胞類型、治療類型、治療領域、最終用戶和地區），2025 年至 2033 年

Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球細胞治療市場規模價值 156.8 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 607.9 億美元，2025-2033 年期間的複合年成長率為 14.51%。北美目前佔據市場主導地位，到 2024 年將佔據超過 59.8% 的顯著市場。隨著全球醫療保健基礎設施的發展，幹細胞研究也不斷進步。患者意識的提高、政府支持的加強和保險覆蓋範圍的擴大也是推動市場向前發展的關鍵因素。

細胞療法 (CT) 涉及移植人體細胞以解決組織和細胞損傷，為各種醫療狀況提供解決方案。這種綜合方法涵蓋了不同類型的細胞，包括造血幹細胞 (HSC)、骨骼肌和間質幹細胞、淋巴細胞、樹突狀細胞和胰島細胞。它的應用範圍不僅限於增強免疫系統以治療癌症，還包括治療自體免疫疾病和傳染病、泌尿系統疾病、關節軟骨損傷、脊髓損傷、免疫系統減弱和神經系統疾病。它在製造再生藥物方面發揮關鍵作用，有助於開發和實施旨在修復組織和器官以及恢復因衰老、疾病或損傷而受到影響的功能的新型治療方法。

全球市場主要受到生物技術的快速進步的推動。與此相符的是，不斷增加的研發活動對市場做出了重大貢獻。此外，政府和私人投資者不斷增加的資金也推動了研究和商業化。除此之外，不斷擴大的臨床試驗活動驗證了細胞療法的有效性和安全性，從而促進了市場的發展。此外，慢性病和退化性疾病的發生率不斷上升，需要先進的治療方案，從而推動市場的發展。人口老化需要再生療法來治療與年齡相關的疾病，從而促進了市場的發展。此外，針對個別患者的個人化細胞療法正在獲得關注，促進市場成長。監管機構為細胞療法核准提供了更清晰的途徑，為市場創造了積極的前景。競爭推動細胞治療產品的創新與多樣化。此外，罕見疾病的日益普及也為市場提供了推動力。

細胞治療市場趨勢/促進因素：

癌症和心臟異常等各種疾病的盛行率不斷上升

各種疾病，特別是癌症和心臟異常的發生率不斷上升，對市場產生了積極影響。由於人口老化、生活方式改變和環境影響等因素，這些疾病的全球負擔穩定上升。細胞療法利用特化細胞的再生和修復特性，在治療和潛在治癒這些疾病方面具有巨大的前景。對於癌症，基於細胞的免疫療法，例如 CAR-T 細胞療法，在靶向和消除癌細胞方面已顯示出顯著的成功。對於心臟異常的情況，基於幹細胞的療法旨在修復受損的心臟組織並改善心臟功能。對這些廣泛傳播且危及生命的疾病的有效治療的迫切需求推動了對細胞治療方法的廣泛研究、開發和投資。

細胞療法臨床研究數量不斷增加

細胞療法臨床研究數量的不斷增加推動了市場的成長。臨床試驗在驗證這些創新療法的安全性和有效性方面發揮著重要作用。隨著臨床研究的深入，對治療癌症、自體免疫疾病和退化性疾病等各種疾病的新療法的需求也日益成長。製藥公司、學術機構和生物技術公司正在積極進行這些試驗，以將基於細胞的療法推向市場。這些研究產生的大量資料證明了細胞療法的治療潛力，也有助於改善治療方案和確定最合適的患者群體。此外，美國FDA等監管機構積極支持並加速細胞療法的核准流程，進一步激勵臨床試驗的進行。因此，越來越多的臨床研究促進了細胞療法的發展、促進了創新並擴大了有需要的患者能夠獲得治療的機會。這一因素強調了臨床研究在推動市場發展方面所扮演的重要角色。

全球醫療保健產業不斷擴張

全球醫療保健產業的不斷擴張為市場提供了無數機會。隨著人口成長、老化以及慢性病負擔加重，對先進醫療治療的需求顯著增加。醫療保健產業的擴張包括開發細胞治療等尖端療法。全球各地的醫療保健系統都認知到細胞療法在治療多種疾病方面的潛力，從癌症和心血管疾病到神經系統疾病和自體免疫疾病。這種認可意味著再生醫學和細胞療法的投資、研究和臨床試驗的增加。此外，隨著新興經濟體醫療基礎設施的改善，包括細胞療法在內的先進醫療手段也更加普及。醫療服務的全球擴張擴大了細胞治療的潛在患者群體，推動了市場成長。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球細胞治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依電池類型

  • 幹細胞
    • 關鍵部分
      • 骨髓
      • 血
      • 臍帶來源
      • 脂肪幹細胞
      • 其他
  • 非幹細胞

第7章：市場區隔：依治療類型

  • 自體
  • 同種異體

第8章：市場區隔：依治療領域

  • 惡性腫瘤
  • 肌肉骨骼疾病
  • 自體免疫疾病
  • 皮膚科
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院和診所
  • 學術和研究機構

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AlloSource
    • Anterogen Co. Ltd.
    • Cells for Cells
    • Holostem Terapie Avanzate Srl
    • JCR Pharmaceuticals
    • Kolon TissueGene Inc.
    • MEDIPOST
    • Mesoblast Limited
    • NuVasive
    • Stemedica Cell Technologies Inc.
    • Stempeutics Research Pvt. Ltd
    • Vericel Corporation
Product Code: SR112025A6231

The global cell therapy market size was valued at USD 15.68 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 60.79 Billion by 2033, exhibiting a CAGR of 14.51% during 2025-2033. North America currently dominates the market, holding a significant market share of over 59.8% in 2024. The advancements in stem cell research are on the rise along with the development of healthcare infrastructure worldwide. Increasing patient awareness, heightened government support and broader insurance coverage are also key factors driving the market forward.

Cell therapy (CT) involves the transplantation of human cells to address tissue and cell damage, providing solutions for various medical conditions. This encompassing approach incorporates different cell types, including hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. Its applications extend beyond immune system enhancement for cancer treatment to encompass the management of autoimmune and infectious diseases, urinary issues, joint cartilage damage, spinal cord injuries, weakened immune systems, and neurological disorders. It plays a pivotal role in manufacturing regenerative medicines, enabling the development and implementation of novel treatments aimed at tissue and organ restoration and the recovery of functions impacted by aging, diseases, or injuries.

The global market is majorly driven by the rapid advancements in biotechnology. In line with this, the increasing research and development activities are significantly contributing to the market. Furthermore, the rising funding from governments and private investors fuels research and commercialization. Apart from this, the expanding clinical trial activities validate the efficacy and safety of cell therapies, catalyzing the market. Moreover, the growing incidence of chronic and degenerative diseases necessitates advanced treatment options, propelling the market. An aging demographic requires regenerative therapies for age-related conditions, bolstering the market. Besides, personalized cell therapies tailored to individual patients are gaining traction, fostering market growth. Regulatory bodies provide clearer pathways for cell therapy approvals, creating a positive outlook for the market. Competition drives innovation and diversification of cell therapy products. Additionally, the escalating prevalence of rare diseases is providing a boost to the market.

Cell Therapy Market Trends/Drivers:

Increasing prevalence of various diseases, such as cancer and cardiac abnormalities

The increasing prevalence of various diseases, particularly cancer and cardiac abnormalities, is favorably impacting the market. The global burden of these diseases has steadily risen due to factors like aging populations, lifestyle changes, and environmental influences. Cell therapy holds immense promise in treating and potentially curing these conditions by utilizing specialized cells' regenerative and reparative properties. For cancer, cell-based immunotherapies, such as CAR-T cell therapy, have shown remarkable success in targeting and eliminating cancer cells. In the case of cardiac abnormalities, stem cell-based therapies aim to repair damaged heart tissue and improve cardiac function. The urgent need for effective treatments for these widespread and life-threatening diseases propels extensive research, development, and investment in cell therapy approaches.

Rising number of clinical studies for cell-based therapies

The rising number of clinical studies for cell-based therapies is fueling the market growth. Clinical trials play a fundamental role in validating the safety and efficacy of these innovative treatments. As clinical studies grow, the demand for novel therapies to address various medical conditions such as cancer, autoimmune diseases, and degenerative disorders grows. Pharmaceutical companies, academic institutions, and biotechnology firms are actively conducting these trials to bring cell-based therapies to the market. The wealth of data generated from these studies demonstrates the therapeutic potential of cell therapies but also aids in refining treatment protocols and identifying the most suitable patient populations. Moreover, regulatory agencies like the FDA in the United States actively support and expedite the approval process for cell-based therapies, further incentivizing the initiation of clinical trials. As a result, the increasing number of clinical studies catalyzes advancing cell therapies, fostering innovation and expanding their accessibility to needy patients. This factor underscores the significant role clinical research plays in propelling the market.

Expanding healthcare industry worldwide

The expanding healthcare industry worldwide is offering numerous opportunities for the market. As populations grow, age, and face an increasing burden of chronic diseases, the demand for advanced medical treatments rises significantly. The healthcare sector's expansion includes the development of cutting-edge therapies like cell-based treatments. Healthcare systems across the globe are recognizing the potential of cell therapy in addressing a wide range of medical conditions, from cancer and cardiovascular diseases to neurological disorders and autoimmune conditions. This recognition translates into increased investment, research, and clinical trials in regenerative medicine and cell therapy. Moreover, as healthcare infrastructure improves in emerging economies, there is greater accessibility to advanced medical treatments, including cell therapies. This global expansion of healthcare services broadens the potential patient pool for cell-based treatments, driving market growth.

Cell Therapy Industry Segmentation:

Breakup by Cell Type:

  • Stem Cell
  • Bone Marrow
  • Blood
  • Umbilical Cord-Derived
  • Adipose-Derived Stem Cell
  • Others
  • Non-stem Cell

Stem cell dominates the market

Stem cells, with their remarkable regenerative potential and ability to differentiate into various cell types, have garnered significant attention in the medical field. These versatile cells are instrumental in treating a wide spectrum of diseases, including degenerative disorders, neurological conditions, and hematological malignancies. The increasing prevalence of age-related diseases and chronic conditions has intensified the demand for effective stem cell-based treatments. Moreover, ongoing research and clinical trials continue to unveil new therapeutic possibilities for stem cells, further fueling market growth. Pharmaceutical and biotechnology firms heavily invest in stem cell research, focusing on developing innovative therapies.

Furthermore, regulatory agencies are recognizing the importance of stem cell therapies, streamlining approval processes, and safety standards. This facilitates the commercialization of stem cell-based treatments, making them more accessible to patients worldwide. The stem cell segment is a powerful driver of growth in the cell therapy market, promising revolutionary solutions for numerous medical challenges.

Breakup by Therapy Type:

  • Autologous
  • Allogeneic

Autologous dominates the market

Autologous therapies involve the extraction, manipulation, and reinfusion of a patient's cells, minimizing the risk of rejection and adverse reactions. This personalized approach has gained prominence in treating various conditions, including cancer, autoimmune diseases, and degenerative disorders. The increasing demand for therapies with higher safety profiles and reduced immune complications has fueled the adoption of autologous cell therapies. These treatments harness the regenerative potential of a patient's cells, addressing unmet medical needs while minimizing the risks associated with allogeneic treatments, where cells are sourced from donors.

Furthermore, advancements in cell processing techniques, such as CAR-T cell therapies for cancer treatment, showcase the remarkable potential of autologous therapies. Regulatory agencies are also streamlining approval pathways for these personalized treatments, expediting their availability to a wider patient population. As a result, the autologous therapy segment is a pivotal driver of growth in the cell therapy market, offering innovative and patient-centric solutions for various medical conditions.

Breakup by Therapeutic Area:

  • Malignancies
  • Musculoskeletal Disorders
  • Autoimmune Disorders
  • Dermatology
  • Others

Malignancies dominate the market

Malignancies, including various types of cancer, present one of the most challenging healthcare concerns globally. Cell therapies, such as CAR-T, have emerged as groundbreaking treatments for these conditions. The growing incidence of cancer and the increasing demand for more effective and targeted therapies have propelled the development and adoption of cell-based treatments. These therapies harness the patient's immune system or engineered cells to target and eliminate cancer cells. Their remarkable success in clinical trials and real-world applications underscores their potential to transform cancer treatment.

Moreover, regulatory agencies are expediting approvals for cell therapies in oncology, streamlining their path to market. As a result, the malignancies-focused segment serves as a critical driver of growth in the cell therapy market, offering renewed hope to cancer patients and contributing to the evolution of cancer care.

Breakup by End User:

  • Hospitals and Clinics
  • Academic and Research Institutes

Hospitals and clinics, with their advanced medical infrastructure and access to a broad patient base, are well-positioned to integrate cell therapy into their treatment protocols. They offer a range of cell-based treatments, including CAR-T cell therapy for cancer and stem cell therapies for various conditions, providing patients with advanced and personalized care options.

Furthermore, the collaboration between hospitals, clinics, and cell therapy companies fosters the expansion of clinical trials and the development of new therapies. As these healthcare facilities continue to recognize the potential of cell therapies in improving patient outcomes, their adoption and utilization of cell-based treatments contribute significantly to the market's overall growth.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America boasts a robust and highly developed healthcare infrastructure, including advanced research institutions, hospitals, and clinical centers. These institutions actively engage in cell therapy research and clinical trials, accelerating the development and adoption of innovative cell-based treatments. The substantial investments in the biotechnology and pharmaceutical sectors facilitate the advancement of cell therapies. Pharmaceutical companies and biotech firms in the region actively contribute to cell therapy research and development, resulting in a steady stream of new therapies.

The regulatory agencies in North America, such as the FDA in the United States, play a crucial role in streamlining the approval process for cell therapies, ensuring they meet rigorous safety and efficacy standards. This regulatory support expedites the commercialization of these treatments. Moreover, the increasing prevalence of chronic diseases, including cancer, fuels the demand for effective and advanced therapies, making cell therapies an attractive option for patients and healthcare providers.

Competitive Landscape:

Top companies are strengthening the market through multifaceted strategies and contributions. These industry leaders prioritize extensive research and development, continuously pushing the boundaries of cell therapies by exploring novel cell types, delivery methods, and applications. They conduct rigorous clinical trials, substantiating the safety and efficacy of their therapies and obtaining regulatory approvals that enhance market credibility. Strategic collaborations and partnerships with research institutions, biotech firms, and healthcare organizations allow them to leverage combined expertise and resources. Top companies often expand their market reach globally, making cell therapies accessible to a broader patient base. Maintaining strict compliance with regulatory standards ensures that their therapies meet stringent safety and quality requirements, instilling confidence among healthcare professionals and patients. Additionally, initiatives to improve patient access, educational campaigns, and strategic acquisitions collectively reinforce their pivotal role in advancing cell therapies and fostering market growth.

The report has provided a comprehensive analysis of the competitive landscape in the cell therapy market. Detailed profiles of all major companies have also been provided.

  • AlloSource
  • Anterogen Co. Ltd.
  • Cells for Cells
  • Holostem Terapie Avanzate S.r.l.
  • JCR Pharmaceuticals
  • Kolon TissueGene Inc
  • MEDIPOST
  • Mesoblast Limited
  • NuVasive
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd
  • Vericel Corporation

Key Questions Answered in This Report

  • 1.What is cell therapy?
  • 2.How big is the cell therapy market?
  • 3.What is the expected growth rate of the global cell therapy market during 2025-2033?
  • 4.What are the key factors driving the global cell therapy market?
  • 5.What is the leading segment of the global cell therapy market based on cell type?
  • 6.What is the leading segment of the global cell therapy market based on therapy type?
  • 7.What is the leading segment of the global cell therapy market based on therapeutic area?
  • 8.What are the key regions in the global cell therapy market?
  • 9.Who are the key players/companies in the global cell therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cell Type

  • 6.1 Stem Cell
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bone Marrow
      • 6.1.2.2 Blood
      • 6.1.2.3 Umbilical Cord-Derived
      • 6.1.2.4 Adipose-Derived Stem Cell
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Non-stem Cell
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Therapy Type

  • 7.1 Autologous
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Allogeneic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Therapeutic Area

  • 8.1 Malignancies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Musculoskeletal Disorders
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoimmune Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dermatology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AlloSource
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Anterogen Co. Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Cells for Cells
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Holostem Terapie Avanzate S.r.l.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 JCR Pharmaceuticals
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kolon TissueGene Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 MEDIPOST
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Mesoblast Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 NuVasive
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Stemedica Cell Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Stempeutics Research Pvt. Ltd
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Vericel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cell Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Therapy Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cell Therapy Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cell Therapy Market: Breakup by Cell Type (in %), 2024
  • Figure 5: Global: Cell Therapy Market: Breakup by Therapy Type (in %), 2024
  • Figure 6: Global: Cell Therapy Market: Breakup by Therapeutic Area (in %), 2024
  • Figure 7: Global: Cell Therapy Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Cell Therapy Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Cell Therapy (Stem Cell) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Cell Therapy (Stem Cell) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Cell Therapy (Non-stem Cell) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cell Therapy (Non-stem Cell) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cell Therapy (Autologous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cell Therapy (Autologous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cell Therapy (Allogeneic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cell Therapy (Allogeneic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cell Therapy (Malignancies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cell Therapy (Malignancies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cell Therapy (Musculoskeletal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cell Therapy (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cell Therapy (Autoimmune Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cell Therapy (Autoimmune Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Cell Therapy (Dermatology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Cell Therapy (Dermatology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Cell Therapy (Other Therapeutic Areas) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Cell Therapy (Other Therapeutic Areas) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Cell Therapy (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Cell Therapy (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Cell Therapy (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Cell Therapy (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Cell Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Cell Therapy Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Cell Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Cell Therapy Industry: SWOT Analysis
  • Figure 81: Global: Cell Therapy Industry: Value Chain Analysis
  • Figure 82: Global: Cell Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Therapy Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Cell Therapy Market Forecast: Breakup by Cell Type (in Million USD), 2025-2033
  • Table 3: Global: Cell Therapy Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
  • Table 4: Global: Cell Therapy Market Forecast: Breakup by Therapeutic Area (in Million USD), 2025-2033
  • Table 5: Global: Cell Therapy Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Cell Therapy Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Cell Therapy Market: Competitive Structure
  • Table 8: Global: Cell Therapy Market: Key Players